Last updated on November 2018

Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer

Brief description of study

The purpose of this study is to evaluate the clinical benefit and safety of Apatinib plus Best Supportive Care in comparison to Placebo plus Best Supportive Care in patients with advanced or metastatic gastric cancer

Clinical Study Identifier: NCT03042611

Contact Investigators or Research Sites near you

Start Over

Kaviraj Muniraju (South Korea)

Chonbuk National University Hospital
Jeonju-si, Korea, Republic of